WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2011138409) COMBRETASTATIN ANALOGS FOR USE IN THE TREATMENT OF CANCER
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2011/138409    International Application No.:    PCT/EP2011/057234
Publication Date: 10.11.2011 International Filing Date: 05.05.2011
IPC:
C07D 233/64 (2006.01), C07D 263/32 (2006.01), C07D 403/04 (2006.01), A61K 31/4164 (2006.01), A61K 31/4178 (2006.01), A61K 31/42 (2006.01), A61P 35/00 (2006.01)
Applicants: UNIVERSITÄT BAYREUTH [--/DE]; Universitätsstr. 30 Bayreuth, 95440 (DE) (For All Designated States Except US).
MARTIN-LUTHER-UNIVERSITÄT HALLE-WITTENBERG [--/DE]; Universitätsplatz 10 Halle, 06108 (DE) (For All Designated States Except US).
SCHOBERT, Rainer [DE/DE]; (DE) (For US Only).
BIERSACK, Bernhard [DE/DE]; (DE) (For US Only).
MÜLLER, Thomas [DE/DE]; (DE) (For US Only)
Inventors: SCHOBERT, Rainer; (DE).
BIERSACK, Bernhard; (DE).
MÜLLER, Thomas; (DE)
Agent: VOSSIUS & PARTNER (NO. 31); Siebertstraße 4 81675 München (DE)
Priority Data:
10161990.6 05.05.2010 EP
Title (EN) COMBRETASTATIN ANALOGS FOR USE IN THE TREATMENT OF CANCER
(FR) ANALOGUES DE LA COMBRÉTASTATINE POUR UTILISATION DANS LE TRAITEMENT DU CANCER
Abstract: front page image
(EN)The present invention relates to specific analogs of combretastatin, in particular the compounds of formula (I) as described and defined herein, and pharmaceutical compositions comprising the compounds, as well as their medical use, in particular in the treatment or prevention of cancer, including multidrug-resistant cancer.
(FR)La présente invention se rapporte à des analogues spécifiques de la combrétastatine, en particulier les composés de formule (I) tels qu'ils y sont décrits et définis, et à des compositions pharmaceutiques comprenant lesdits composés, ainsi que leur utilisation médicale, en particulier dans le traitement ou la prévention du cancer, y compris le cancer multirésistant.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)